skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
The U.S. 3-phase clinical results of ‘Jeuveau’ is published on an SCI-level international journal
Date 2019-03-25 Hit 553
News List
Prev Daewoong Pharmaceutical acquires the sales rights for Vivotif, an orally injected typhoid fever vaccine.
Next The clinical findings of Botulinum Toxin manufactured by Daewoong have been published on international journal regarding the comparison with Botox